Malignancy in endometrial polyps: a 12-year experience

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 5, 2009, Pages 462.e1-462.e4

  Baiocchi, Gabriela ^a   Manci, Natalina ^b   Pazzaglia, Michela ^a   Giannone, Laura ^a   Burnelli, Liliana ^a   Giannone, Ettore ^a   Fratini, Daniela ^a   Di Renzo, Gian Carlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

endometrial; endometrial cancer; hysteroscopy; polyps; risk factors

Indexed keywords

TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BENIGN TUMOR; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MENOPAUSE; PRECANCER; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERUS BLEEDING;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; POLYPS; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 70350571108     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.05.055     Document Type: Article

References (26)

1. Schlaen I., Bergeron C., Ferenczy A., Wong P., and Naves A. Endometrial polyps: a study of 204 cases. Surg Pathol 1 (1988) 375-382
2. DeWaay D.J., Syrop C.H., Nygaard I.E., Davis W.A., and Van Voorhis B.J. Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100 (2002) 3-7
3. De Vries L., Dijkhuizen F., Mol B., Brolmann H., Moret E., and Heintz A. Comparison of transvaginal sonography, saline infusion sonography, and hysteroscopy in premenopausal women with abnormal uterine bleeding. J Clin Ultrasound 28 (2000) 217-223
4. Widrich T., Bradley L., Mitchinson A., and Collins R. Comparison of saline infused sonography with office hysteroscopy for the evaluation of the endometrium. Am J Obstet Gynecol 174 (1996) 1327-1334
5. Sherman M.E., Mazur M.T., and Kurman R.J. Benign diseases of the endometrium. In: Kurman R.J. (Ed). Blaunstein's pathology of the female genital tract. 3rd ed. (2002), Springer, New York, NY
6. Goldstein S.R., Monteagudo A., Popiolek D., Mayberry P., and Timor-Tritsch I. Evaluation of endometrial polyps. Am J Obstet Gynecol 186 (2002) 669-674
7. Caspi B., Appelman Z., Goldchmit R., Ashkenazi M., Haruvy Y., and Hagay Z. The bright edge of the endometrial polyp. Ultrasound Obstet Gynecol 15 (2000) 327-330
8. Clevenger-Hoeft M., Syrop C.H., Stovall D.W., and Van Voorhis B.J. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol 94 (1999) 516-520
9. Cohen I., Azaria R., Aviram R., et al. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings. Gynecol Obstet Invest 48 (1999) 187-192
10. Orovieto R., Bar-Hava I., Dicker D., Bar J., Ben-Rafael Z., and Neri A. Endometrial polyps during menopause: characterization and significance. Acta Obstet Gynecol Scand 78 (1999) 883-886
11. Ben-Arie A., Goldchmit C., Laviv Y., et al. The malignant potential of endometrial polyps. Eur J Obstet Gynecol 115 (2004) 206-210
12. Sant'Ana de Almeida E.C., Nogueira A.A., Candido dos Reis F.J., Zambelli Ramalho L.N., and Zucoloto S. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas 49 (2004) 229-233
13. Cheng W.F., Lin H.H., Torng P.L., and Huang S.C. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 66 (1997) 233-237
14. McGurgan P., Taylor L.J., Duffy S.R., and O'Donovan P.J. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT. Maturitas 53 (2006) 454-461
15. Salm R. The incidence and significance of early carcinomas in endometrial polyps. Pathology 108 (1972) 47-53
16. Anastasiadis P.G., Koutlaki N.G., Skaphida P.G., Galazios G.C., Tsikouras P.N., and Liberis V.A. Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 21 (2000) 180-183
17. Wolfe S.A., and Mackles A. Malignant lesions arising from benign endometrial polyps. Obstet Gynecol 20 (1962) 542-550
18. Bakour S.H., Khan K.S., and Gupta J.K. The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand 79 (2000) 317-320
19. Savelli L., De Iaco P., Santini D., et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 188 (2003) 927-931
20. In: Kurman R.J. (Ed). Blaustein's pathology of the female genital tract. 5th ed. (2002), Springer-Verlag, New York
21. Hassa H., Tekin B., Senses T., Kaya M., and Karatas A. Are the site, diameter, and number of endometrial polyps related with the symptomatology?. Am J Obstet Gynecol 194 (2006) 718-721
22. Giordano G., Gnetti L., Merisio C., and Melpignano M. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas 20 (2007) 190-197
23. Antunes Jr. A., Costa-Paiva L., Arthuso M., Costa J.V., and Pinto-Neto A.M. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy. Maturitas 57 (2007) 415-421
24. Hileeto D., Fadare O., Martel M., and Zheng W. Age dependent association of endometrial polyps with increased risk of cancer involvement. World J Surg Oncol 3 (2005) 8
25. Oguz S., Sargin A., Kelekci S., Aytan H., Tapisiz O.L., and Mollamahmutoglu L. The role of hormone replacement therapy in endometrial polyp formation. Maturitas 50 (2005) 231-236
26. Bergman L., Beelen M.L., Gallee M.P., Hollema H., Benraadt J., and van Leeuwen F.E. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen. Lancet 356 (2000) 881-887